DWM
UTHR icon

Drive Wealth Management’s United Therapeutics UTHR Stock Holding History

Drive Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Buy
438
+25
+6% +$14.1K 0.04% 373
2026
Q1 		$245K Sell
413
-99
-19% -$49.3K 0.05% 297
2025
Q4 		$249K Buy
+512
New +$238K 0.05% 300

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Drive Wealth Management's UTHR Position: Q2 2026 in Review

Drive Wealth Management increased its United Therapeutics (UTHR) stake by 6.1% in Q2 2026, buying an estimated $14.1K and bringing the position to 438 shares worth $237K. The position accounts for 0.04% of the portfolio, ranked #373.

Drive Wealth Management first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. The position peaked at $249K in Q4 2025. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Drive Wealth Management held 438 shares of United Therapeutics worth $237K as of Q2 2026.
  • Drive Wealth Management bought 25 United Therapeutics shares in Q2 2026, an estimated $14.1K.
  • United Therapeutics made up 0.04% of Drive Wealth Management's portfolio in Q2 2026, its #373 holding.
  • Drive Wealth Management first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Drive Wealth Management's United Therapeutics position peaked at $249K in Q4 2025.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Drive Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.